Portfolio Valuation & Prioritization Analysis
SITUATION
A public biopharmaceutical company with a diverse product pipeline required a comprehensive understanding of the intrinsic value of their portfolio to inform their long-range planning, evaluate potential financing opportunities, and provide a more informed and cohesive perspective for the Board of Directors and investor relations.
OUR ROLE
Leading a cross-functional team comprised of personnel from executive management, finance, program management, commercial, and business development, we built a comprehensive valuation model and short-term forecast. We identified key inputs and tailored the model to account for the unique aspects of the company’s assets. Extensive primary and secondary research validated the model’s design, accuracy, and reliability.
IMPACT
The portfolio valuation analysis was a linchpin for strategic decision-making and financing requirements. Our team's integration with the client's executive committee elevated our role to that of a valued and contributing member of the leadership team, fostering ongoing collaboration and alignment.
